品牌
经销商厂商性质
上海市所在地
Human EGF Recombinant Protein Carrier-Free
面议Anti-Mouse NKG2A/C/E PerCP-eFluor® 710
面议Mouse IFN gamma Platinum ELISA (extra sensitive)
面议Anti-Mouse CD38 PerCP-eFluor® 710
面议Anti-Human CD279 (PD-1) PE-Cy7
面议Human VLDL 人极低密度脂蛋白
面议[I125] Ox-LDL 碘125标记人氧化低密度脂蛋白
面议DiI-Ox-LDL DiI标记人氧化低密度脂蛋白
面议Human Ox-LDL 人氧化低密度脂蛋白
面议[I125] Human Ac-LDL 碘125标记乙酰化人低密度脂蛋白
面议Dio-Ac-LDL DiO标记乙酰化人低密度脂蛋白
面议DiI-Ac-LDL DiI标记乙酰化人低密度脂蛋白
面议Description: CCL19, also known as MIP-3 beta (Macrophage Inflammatory Protein 3 beta), is a member of the CC- subfamily of chemokines. It is most closely related to CCL21, with which it shares 32% amino acid sequence homology. CCL19 and CCL21 are expressed mainly by stromal cells in the T cell-rich zones of lymph nodes. They are critical mediators of the homeostatic trafficking of naïve T cells and activated dendritic cells into the secondary lymphoid organs. CCL19 and CCL21 also play a role in T cell priming and activation, as well as the recruitment of lymphocytes to inflamed tissue. Both proteins signal via the G protein-coupled receptor, CCR7, which is expressed on T cells and mature dendritic cells. Although CCL19 and CCL21 both exhibit the same affinity for CCR7, only the binding of CCL19 results in the desensitization and internalization of the receptor.